Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (2010) (ISBN 0309153328) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Public Engagement and Clinical Trials: New Models and Disruptive Technologies: Workshop Summary (2011) (ISBN 0309219299) Victoria Weisfeld, Rebecca A. English, Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Review of the Fialuridine (FIAU) Clinical Trials (1995) (ISBN 0309052793) Frederick J. Manning and Morton Swartz, Editors; Committee to Review the Fialuridine (FIAU/FIAC) Clinical Trials, Institute of Medicine


• Extending Medicare Reimbursement in Clinical Trials (2000) (ISBN 0309068886) Henry J. Aaron and Hellen Gelband, Editors; Committee on Routine Patient Care Costs in Clinical Trials for Medicare Beneficiaries, Institute of Medicine


• Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making:Workshop Report (1999) (ISBN 0309065941) Jonathan R. Davis, Vivian P. Nolan, Janet Woodcock, and Ronald W. Estabrook, Editors; Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions:Issues for the Government and Private Sector (1995) (ISBN 0309052440) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) (ISBN 030910078X) Committee on Clinical Trial Registries


• Expanding Access to Investigational Therapies for HIV Infection and AIDS (1991) (ISBN 0309044901) Roundtable for the Development of Drugs and Vaccines Against AIDS, Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (2005) (ISBN 0309096391)


• The Prevention and Treatment of Missing Data in Clinical Trials (2010) (ISBN 0309158141) Panel on Handling Missing Data in Clinical Trials; National Research Council


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine